about
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in miceProduction of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India.Anti-trichophyton activity of protocatechuates and their synergism with fluconazole.Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens.Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and TreActivities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for ReComparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.Versatility of aminoglycosides and prospects for their future.The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans.Decimal assay for additivity of drugs permits delineation of synergy and antagonismReproducibility of the microdilution checkerboard method for antibiotic synergyProspective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureusCombination therapy for treatment of infections with gram-negative bacteria.Synergistic interactions of methanolic extract of Acacia mearnsii De Wild. with antibiotics against bacteria of clinical relevanceFlorfenicol As a Modulator Enhancing Antimicrobial Activity: Example Using Combination with Thiamphenicol against Pasteurella multocida.Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinationsEffects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain.Bacterial responses to antibiotics and their combinations.Antibacterial synergic effect of honey from two stingless bees: Scaptotrigona bipunctata Lepeletier, 1836, and S. postica Latreille, 1807.Bacteriostatic antimicrobial combination: antagonistic interaction between epsilon-viniferin and vancomycin against methicillin-resistant Staphylococcus aureus.Aminoglycosides: An Overview.Dual action antimicrobial surfaces via combined nitric oxide and silver release.Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species.Selected Antimicrobial Activity of Topical Ophthalmic Anesthetics.Synergism between two amphenicol of antibiotics, florfenicol and thiamphenicol, against Staphylococcus aureus.Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases.Sensitization of Gram-negative bacteria to rifampin and OAK combinations.Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata.Antibiotic Driven Changes in Gut Motility Suggest Direct Modulation of Enteric Nervous System.Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus.In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.Antibacterial Diamines Targeting Bacterial Membranes.In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate.In vitro antibacterial and time-kill evaluation of the Erythrina caffra Thunb. extract against bacteria associated with diarrhoea.Evaluation of combination effects of ethanolic extract of Ziziphus mucronata Willd. subsp. mucronata Willd. and antibiotics against clinically important bacteria
P2860
Q28476689-9782E6EA-7593-4723-A517-3816AF704F4FQ30390187-DF5D564D-EB4B-431E-A084-0B07DC2EE062Q33862427-B284F0B7-7CFD-4D18-AC06-899A004B3C84Q34384513-1FDE581A-8004-4988-A8BD-B640EE286AB2Q34722117-25791945-09BE-46D9-9D32-803AB5AC920DQ34922363-0DFF1CB2-D558-488B-B3BF-4718BA038E26Q35014416-86BA5E85-EB57-48C9-9DE4-39905B076FD4Q35124179-0C355C6A-29F4-4909-8BED-DCD6F553CE1AQ35135561-B5DAEFAF-D986-4549-BF76-2307350C1198Q35176271-89AB4904-E9BE-4D25-83F0-1E7206EDB379Q35804176-9021243C-1F1E-4677-A3B9-55C47C8A6F01Q35808612-7C015AD1-B1F2-4F6B-9981-C6FE227D8257Q35810795-FF8AC421-91C5-4F74-948B-584E72307677Q35821552-FFF795A3-0797-4BF8-9CCA-5B1E4F6815EAQ36017541-4034B3C6-23AA-4F29-B9EE-76F2D681F8F8Q36156077-9D09F502-E014-4393-BF71-479DF2AFFDD0Q36197342-3331CA79-20B8-4CAF-854D-8E7F6E303D51Q36740306-0FB5325C-C8CD-4A44-A4D6-4292A400B2B1Q37144883-ED0A4E21-DCDA-425E-970B-270F650222BCQ37598755-F919021F-3760-43F1-BD9B-7B1898AE6687Q38371796-660D1233-C1F6-48A6-B537-4CAA8C19CB1DQ38380313-A2F43FFB-B986-457A-8FB9-09F423AB0736Q38690166-880D48CC-5D97-4BAF-A0B9-CF53C68BF50BQ38851189-B43D7C05-9936-4C46-A3B7-4132651E07EEQ38957901-CB8B9CC9-F599-4CE8-9412-B74649C5A385Q39478915-517F5B3B-6C5E-4AEF-BD82-71F919E7C10AQ40605403-0094C1FA-9C49-4C39-9A4E-4902358AFECFQ40796762-2B2883F1-3D6C-40E0-B3A1-20E8DFE8BE92Q40943601-EEC05491-AEB0-4514-9C5B-6597E122B2F2Q41420121-D9A78BB8-1905-40CF-857C-1E1541BA0B1AQ42932836-DFD0ECCB-AA5B-42EE-AC06-53B580B6A94EQ43139342-84453E30-8E66-4EAE-BBFB-25B92757EC0FQ43189837-0477FF2C-979E-4DBD-9D8A-589BDA05937FQ44506036-15E2C94D-B2B6-4624-8A94-FE21F6087A48Q46499284-33033B26-58B0-4686-B154-924CAB5FBB2FQ46557679-437C2DDA-FB6D-4E40-A642-7EF6604146B4Q53153422-327D035B-1897-45CE-B326-C596C991812EQ54631379-F213894C-9137-4266-AC9D-62B34B765924Q55651790-F266F7E0-565E-42C8-BAE2-C92A8461C583Q59034494-0DA81052-CF06-4E84-850B-549973D7BF0F
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Antibiotic combinations: should they be tested?
@ast
Antibiotic combinations: should they be tested?
@en
type
label
Antibiotic combinations: should they be tested?
@ast
Antibiotic combinations: should they be tested?
@en
prefLabel
Antibiotic combinations: should they be tested?
@ast
Antibiotic combinations: should they be tested?
@en
P2860
P356
P1476
Antibiotic combinations: should they be tested?
@en
P2093
Eliopoulos CT
Eliopoulos GM
P2860
P304
P356
10.1128/CMR.1.2.139
P407
P577
1988-04-01T00:00:00Z